Xeomin has been approved by Health Canada as the newest wrinkle reduction injectable to temporarily
improve the appearance of frown lines. Xeomin has been approved in Europe since 2005 and is currently
being used in other countries around the world.
Xeomin cosmetic contains botulinum toxin type A that when injected, can reduce facial movements in
the area creating a softened, more refreshed look.
[services_sidebar]